Aglae Rene, MD
Interventional Cardiology · Mount Kisco, NYNPI 1831415090
Payments from drug & device makers
Across 54 payments — averaging $65.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spectrawave, Inc$844
- Edwards Lifesciences$556
- Medtronic$542
- Cardiovascular Systems Inc.$370
- Shockwave Medical, Inc$363
- Boston Scientific$362
- plus $495 from 5 others
What the payments were for
- Travel & lodging$44713%
- Food & beverage$3,08587%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spectrawave, Inc | 6 | $844 |
| Edwards Lifesciences | 9 | $556 |
| Medtronic(2 entities) | 12 | $542 |
| Cardiovascular Systems Inc. | 4 | $370 |
| Shockwave Medical, Inc | 9 | $363 |
| Boston Scientific | 3 | $362 |
| Abbott | 7 | $164 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Heartflow, Inc. | 1 | $111 |
| Irhythm Technologies, Inc. | 1 | $68 |
| Cathworks, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HyperVue Imaging System$764
- Starlight Imaging Catheter$764
- X1-FFR$637
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$342
- Diamondback Coronary$259
- AVVIGO Guidance System$220
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$143
- CoreValve Evolut$125
- CAMZYOS$125
- Abre$121
- Edwards SAPIEN 3 Transcatheter Heart Valve$115
- FFRct$111
- CLINICAL TRIAL PRODUCT$110
How this compares
$3,532 in reported general payments places this provider in the 25th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 300 | $387,456 |
| XareltoRivaroxaban | 120 | $147,189 |
| Repatha SureclickEvolocumab | 62 | $68,741 |
| EntrestoSacubitril/Valsartan | 43 | $52,221 |
| FarxigaDapagliflozin Propanediol | 21 | $24,527 |
| JardianceEmpagliflozin | 11 | $16,623 |
| BrilintaTicagrelor | 11 | $11,034 |
| Rosuvastatin Calcium | 526 | $10,128 |
| Metoprolol Succinate | 535 | $7,638 |
| Atorvastatin Calcium | 603 | $7,490 |
| Ezetimibe | 182 | $6,889 |
| Ranolazine ErRanolazine | 25 | $6,355 |
| Losartan Potassium | 289 | $3,557 |
| Amlodipine Besylate | 486 | $3,343 |
| Pravastatin Sodium | 176 | $2,566 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Mount Kisco
- Martin LeonNew York$13.5M
- David CohenRoslyn$9.8M
- Susheel KodaliNew York$6M
- Mohamed Azeem LatibBronx$4.6M
- Richard ShlofmitzRoslyn$4.5M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
- Annapoorna KiniNew York$3.5M
- Sahil ParikhNew York$2.7M
- George DangasNew York$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.